Georgia hospitals test ‘game-changer’ pancreatic cancer drugs
Atlanta Journal-Constitution • • health
Key Points:
- Retired Atlanta attorney David Stockton has experienced significant health improvements more than a year after taking daraxonrasib, an experimental drug for metastatic pancreatic cancer.
- Stockton is now able to walk up to five miles daily, hike the Appalachian Trail, and enjoy time with his family despite battling one of the deadliest cancers in the U.S.
- Daraxonrasib received early access approval from the FDA in May and has shown greater effectiveness in shrinking tumors with fewer side effects compared to traditional chemotherapy.
- The drug offers new hope for patients with metastatic pancreatic cancer, which is the nation’s third-deadliest cancer type.